3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 24 0 0 0 0 0 0 0999 V2000
-4.8325 -0.5961 0.0004 S 0 0 0 0 0 0 0 0 0 0 0 0
4.8274 0.9791 0.0008 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0695 1.0102 -0.0006 N 1 0 0 0 0 0 0 0 0 0 0 0
-0.2346 -1.2062 -0.0007 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.0176 1.2448 -0.0002 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2213 0.5470 -0.0003 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0915 -0.8390 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9021 -0.0742 -0.0008 C 1 0 0 0 0 0 0 0 0 0 0 0
2.4535 1.2015 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3735 0.0228 -0.0003 C 1 0 0 0 0 0 0 0 0 0 0 0
2.2493 -1.6352 0.0003 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5954 0.3935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4973 -0.9997 0.0004 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1897 -1.0888 0.0004 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3162 1.0404 0.0009 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3517 1.9816 -0.0006 H 0 0 0 0 0 0 0 0 0 0 0 0
2.5216 2.2839 -0.0002 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1835 -2.7185 0.0004 H 0 0 0 0 0 0 0 0 0 0 0 0
4.3951 -1.6137 0.0008 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9213 -2.1363 0.0006 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.0266 1.8556 0.0016 H 0 0 0 0 0 0 0 0 0 0 0 0
5.5077 0.2840 0.0011 H 0 0 0 0 0 0 0 0 0 0 0 0
1 14 1 0 0 0 0
1 15 1 0 0 0 0
2 12 1 0 0 0 0
2 22 1 0 0 0 0
3 6 1 0 0 0 0
3 8 1 0 0 0 0
3 16 1 0 0 0 0
4 7 1 0 0 0 0
4 8 2 0 0 0 0
5 10 1 0 0 0 0
5 15 2 0 0 0 0
6 7 2 0 0 0 0
6 9 1 0 0 0 0
7 11 1 0 0 0 0
8 10 1 0 0 0 0
9 12 2 0 0 0 0
9 17 1 0 0 0 0
10 14 2 0 0 0 0
11 13 2 0 0 0 0
11 18 1 0 0 0 0
12 13 1 0 0 0 0
13 19 1 0 0 0 0
14 20 1 0 0 0 0
15 21 1 0 0 0 0
M ISO 3 3 15 8 13 10 13
4. 国际命名与标识
4.1 IUPAC Name
2-((413C)1,3-thiazol-4-yl)-3H-benzimidazol-5-ol
4.2 InChl
InChI=1S/C10H7N3OS/c14-6-1-2-7-8(3-6)13-10(12-7)9-4-15-5-11-9/h1-5,14H,(H,12,13)/i9+1,10+1,13+1
4.3 InChlKey
VNENJHUOPQAPAT-GQSWDAPCSA-N
4.4 Canonical SMILES
C1=CC2=C(C=C1O)NC(=N2)C3=CSC=N3
4.5 lsomeric SMILES
C1=CC2=C(C=C1O)[15NH][13C](=N2)[13C]3=CSC=N3
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病